what is Uh, what is type III secretory factors in case of, uh, Salmonella?
Reading File
Finding Sources
Searching the Web
Salmonella type III secretion system virulence factors mechanism
Reading File
Reading File
Reading File
Reading File
I now have comprehensive information from multiple authoritative textbooks. Here is a full explanation:
Type III Secretion System (T3SS) in Salmonella
What is the Type III Secretion System?
The Type III Secretion System (T3SS) is essentially a molecular syringe - a needle-like complex made up of approximately 20 proteins that Salmonella (and other gram-negative bacteria like Shigella, Yersinia, Pseudomonas, Chlamydia) use to directly inject virulence proteins (effectors) into host eukaryotic cells. Without this system, the bacteria have greatly diminished virulence.
- Medical Microbiology 9e, p. 297
Salmonella Has TWO Distinct T3SS Systems
Salmonella is unique in having two separate T3SS, each encoded on a different Salmonella Pathogenicity Island (SPI):
1. T3SS-1 (Encoded by Pathogenicity Island I / SPI-1)
- Role: Invasion of intestinal epithelial cells (M cells and enterocytes)
- Mechanism:
- After ingestion, Salmonella reaches the small intestine and targets M cells in Peyer's patches and enterocytes
- T3SS-1 injects Salmonella-secreted invasion proteins (Ssps) into the host cell cytoplasm
- These effector proteins activate host Rho GTPases, triggering dramatic actin cytoskeleton rearrangement
- This causes membrane ruffling - the host cell membrane extends out and wraps around the bacteria, pulling them in via bacterium-mediated endocytosis (macropinocytosis)
- Bacteria then reside inside endocytic vacuoles where they replicate
- Harrison's Principles, 22e, p. 1358 | Robbins & Cotran Pathologic Basis of Disease
2. T3SS-2 (Encoded by Pathogenicity Island II / SPI-2)
- Role: Intracellular survival - evading host immune destruction inside macrophages
- Mechanism:
- After crossing the epithelium, Salmonella is phagocytosed by macrophages
- T3SS-2 delivers effector proteins across the phagosome membrane into the macrophage cytoplasm
- Key effector: SifA - alters the composition of the Salmonella-containing vacuole (SCV) to prevent its destruction (avoids fusion with lysosomes)
- Other regulatory systems (e.g., PhoP/PhoQ) also help remodel the outer membrane to resist microbicidal activities
- Janeway's Immunobiology 10e, p. 2782 | Harrison's Principles 22e
Key Effectors and Their Actions
| Effector / Factor | SPI Encoded | Action |
|---|---|---|
| Ssps (Salmonella-secreted invasion proteins) | SPI-1 | Actin rearrangement → membrane ruffles → bacterial uptake |
| SifA | SPI-2 | Remodels Salmonella-containing vacuole (SCV), prevents lysosomal destruction |
| Hepoxilin A3 inducer | - | Stimulates neutrophil chemotaxis into intestinal lumen, potentiates mucosal damage |
| GtgA, PipA, GogA | SPI-2 | Zinc metalloproteases that cleave NF-κB subunits (p65, RelB) to attenuate inflammation |
| CigR | SPI-3 | Anti-virulence factor; controls the virulence threshold of MgtC |
Summary of the Invasion Process
- Salmonella ingested → survives gastric acid → reaches small intestine
- T3SS-1 fires → injects effectors → actin rearrangement → bacterium-mediated endocytosis into M cells/enterocytes
- Bacteria survive in endocytic vacuoles → transported to blood/lymphatics
- Phagocytosed by macrophages → T3SS-2 fires → remodels phagosome → intracellular survival and replication
- Typhoidal strains disseminate via lymphatics to liver, spleen, bone marrow (enteric fever)
Why It Matters Clinically
- The T3SS is the primary reason Salmonella is so invasive - it bypasses normal immune defenses at the mucosal surface
- Loss of gastric acid (PPIs, achlorhydria, age <1 year) reduces the inoculum needed because the bacteria face less killing before reaching the T3SS-active intestinal environment
- Genetic defects in Th1 or Th17 immunity increase risk of disseminated salmonellosis, since these T-cell pathways are critical for controlling the intracellular phase
Sources: Medical Microbiology 9e (Murray) | Harrison's Principles of Internal Medicine 22e | Robbins & Cotran Pathologic Basis of Disease | Janeway's Immunobiology 10e
what happened
Could you clarify what you mean? Are you asking:
- About the previous answer - did something not display correctly, or was something confusing?
- About a news/current event - something that happened in the world?
- About a medical topic - what happens during Salmonella infection (continuing from the last question)?
Let me know and I'll help right away!
you stopped abruptly
You're right, my apologies! The previous answer was actually complete - nothing got cut off. Here's a recap of everything that was covered:
Type III Secretion System (T3SS) in Salmonella - Full Summary
What is T3SS?
A molecular syringe (~20 proteins) that directly injects bacterial virulence proteins (effectors) into host eukaryotic cells. Without it, Salmonella loses most of its virulence.
Two T3SS Systems in Salmonella
T3SS-1 (SPI-1) - Invasion
- Fires at the intestinal epithelium
- Injects Ssps (Salmonella-secreted invasion proteins)
- These activate Rho GTPases → actin rearrangement → membrane ruffling → bacteria pulled into the cell via endocytosis
- Bacteria survive inside endocytic vacuoles and replicate
T3SS-2 (SPI-2) - Intracellular Survival
- Fires inside macrophages after phagocytosis
- Injects effectors across the phagosome membrane
- Key effector SifA remodels the Salmonella-containing vacuole (SCV) - prevents lysosomal fusion and destruction
- Allows bacteria to survive and replicate inside macrophages
Key Effectors
| Effector | Role |
|---|---|
| Ssps | Actin rearrangement → invasion |
| SifA | Remodels SCV, avoids lysosomal killing |
| GtgA / PipA / GogA | Cleave NF-κB subunits → dampen inflammation |
| Hepoxilin A3 inducer | Recruits neutrophils → mucosal damage |
| CigR | Anti-virulence, controls MgtC threshold |
Step-by-Step Pathogenesis
- Salmonella ingested → survives stomach acid
- Reaches small intestine → targets M cells in Peyer's patches
- T3SS-1 fires → actin rearrangement → bacterium-mediated endocytosis
- Bacteria transported to blood/lymphatics
- Phagocytosed by macrophages → T3SS-2 fires → SCV remodeling → intracellular survival
- Typhoidal strains (S. Typhi, S. Paratyphi) disseminate to liver, spleen, bone marrow, lymph nodes → enteric (typhoid) fever
Clinical Relevance
- Loss of gastric acid (PPIs, achlorhydria) lowers the infective dose
- Defects in Th1/Th17 immunity → risk of disseminated salmonellosis
- T3SS is the primary drug target being studied for anti-virulence therapies
Nothing was actually cut off - that was the full answer! Let me know if you want me to go deeper on any specific part.
But how is this clinically relevant to read for USMLE? Like, what's the need to know about this system? Like, how can this be tested?
Great question. Here's the honest USMLE perspective:
What You Actually Need to Know About T3SS for USMLE
The Core Testable Concept (High Yield)
The USMLE doesn't test the names of individual effectors (SifA, GtgA, etc.). What is tested is the consequence of the T3SS - specifically:
Salmonella survives INSIDE macrophages - this is the #1 high-yield fact.
This distinguishes it from bacteria that are killed by macrophages.
How It Gets Tested
1. Intracellular survival question
"Which of the following organisms can survive and replicate within macrophages?"
Answer: Salmonella (along with Mycobacterium, Listeria, Brucella, Leishmania)
The T3SS-2 (SPI-2) is the mechanism behind this - but USMLE asks about the outcome, not the molecular machinery.
2. Mechanism of invasion question
"A patient develops salmonellosis. Which mechanism allows the bacteria to enter non-phagocytic epithelial cells?"
Answer: Bacterium-mediated endocytosis via actin rearrangement (T3SS-1 doing this)
Contrast this with Listeria which uses internalin, or Shigella which uses a similar but slightly different mechanism.
3. Pathogenicity island comparison
| Feature | SPI-1 | SPI-2 |
|---|---|---|
| Location targeted | Intestinal epithelium | Inside macrophages |
| Result | Invasion / gastroenteritis | Systemic spread / typhoid |
This distinction explains why S. Typhi causes systemic typhoid fever while non-typhoidal Salmonella causes mainly self-limited gastroenteritis - SPI-2 allows deeper dissemination.
3. Virulence factor comparison table (very commonly tested)
| Organism | Virulence mechanism | Clinical result |
|---|---|---|
| Salmonella | T3SS → intracellular survival in macrophages | Typhoid fever, bacteremia |
| Shigella | T3SS → actin-based motility inside cells | Dysentery, NO bacteremia |
| Yersinia | T3SS → blocks phagocytosis | Mesenteric adenitis, plague |
| E. coli (EPEC) | T3SS → attaching-effacing lesions | Watery diarrhea |
The One-Line USMLE Summary
Salmonella uses a type III secretion system to invade gut epithelial cells (SPI-1) and survive inside macrophages (SPI-2) - this intracellular survival is what allows systemic dissemination in typhoid fever.
Know that mechanism, know which bugs share it, know how it differs from Shigella (which does NOT cause bacteremia despite a similar T3SS), and you've covered everything USMLE will ask about this topic.
what is attaching effacing lesions
Finding Sources
Reading File
Reading File
Here's a clear breakdown, with USMLE relevance built in:
Attaching and Effacing (A/E) Lesions
What Does It Mean Literally?
- Attaching = the bacteria tightly stick to the surface of intestinal epithelial cells
- Effacing = they destroy (efface) the microvilli on those cells
So an A/E lesion = bacteria attached to a bare, microvillus-destroyed patch of intestinal epithelium.
Which Bacteria Cause This?
The classic bugs are:
- EPEC - Enteropathogenic E. coli (children in developing countries, watery diarrhea)
- EHEC - Enterohemorrhagic E. coli O157:H7 (bloody diarrhea, HUS)
- Citrobacter rodentium (mouse model used to study it)
Step-by-Step Mechanism (T3SS is central here too)
-
Initial attachment - bacteria loosely adhere to the intestinal epithelial cell (IEC) surface via bundle-forming pili (BFP)
-
T3SS fires - injects a key protein called Tir (Translocated Intimin Receptor) into the host cell membrane
-
Intimin binds Tir - the bacterial surface protein intimin now locks onto the Tir protein it just inserted into the host cell. This creates intimate, tight attachment - the bacterium is essentially anchored using a receptor it planted itself
-
Actin reorganization - underneath the attached bacterium, host actin polymerizes into a cup-like "pedestal" that props the bacterium up
-
Microvilli are effaced - the surrounding microvilli collapse and disappear, leaving a bare patch. This is the A/E lesion.
What Does This Look Like?
On electron microscopy (this is a classic USMLE image trigger):
- Bacteria sitting on top of a raised actin pedestal
- Surrounding microvilli are gone (effaced)
- The cell is intact (bacteria do NOT invade)
Clinical Consequence
- Loss of microvilli = loss of absorptive surface → watery diarrhea (EPEC)
- EHEC adds Shiga-like toxin on top of this → bloody diarrhea + HUS (hemolytic uremic syndrome)
- The bacteria stay on the surface - they do NOT invade, do NOT cause bacteremia (unlike Salmonella)
USMLE High-Yield Summary
| Feature | Detail |
|---|---|
| Bacteria | EPEC, EHEC (E. coli O157:H7) |
| Mechanism | T3SS injects Tir → intimin binds Tir → actin pedestal + microvilli effacement |
| Key gene locus | LEE (Locus of Enterocyte Effacement) - the pathogenicity island encoding all this |
| Result | Watery diarrhea (EPEC) or bloody diarrhea + HUS (EHEC) |
| Invasion? | NO - bacteria stay on surface |
| Buzzword on EM | Actin pedestal under attached bacterium |
How This Connects Back to Salmonella
Both Salmonella and EPEC/EHEC use T3SS, but the outcome is completely different:
- EPEC/EHEC: T3SS injects Tir → pedestal formation, stays on surface
- Salmonella: T3SS injects Ssps → full actin rearrangement → bacterium gets swallowed into the cell
Same tool (T3SS), completely different result. That contrast is very testable on USMLE.
Sources: Yamada's Textbook of Gastroenterology 7e | Janeway's Immunobiology 10e | Goldman-Cecil Medicine
Students think any process with microthrombi and low platelets must be DIC. In fact, HUS involves localized thrombi formation at sites of endothelial damage (toxin-mediated), while DIC involves systemic activation of the entire coagulation cascade. In HUS, PT, PTT, and fibrinogen are normal because the clotting factors are not being consumed — only platelets are consumed at damage sites. ultra compact sticky note from above concept.
HUS vs DIC
HUS = localized endothelial damage (Shiga toxin) → microthrombi only where vessels are injured → platelets consumed, clotting factors NOT consumed
Labs: ↓ Platelets | PT/PTT normal | Fibrinogen normal
DIC = systemic coagulation activation → everything consumed everywhere
Labs: ↓ Platelets | ↑ PT/PTT | ↓ Fibrinogen | ↑ D-dimer
Low platelets + normal PT/PTT = HUS, not DIC.
This is a shared conversation. Sign in to Orris to start your own chat.